[{"address1": "18702 N. Creek Parkway", "address2": "Suite 100", "city": "Bothell", "state": "WA", "zip": "98011", "country": "United States", "phone": "610-321-3700", "website": "https://immunome.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immunome, Inc., a biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises AL102, an investigational gamma secretase inhibitor currently in evaluation in a Phase 3 trial for the treatment of desmoid tumors; and preclinical assets consist of IM-1021, a receptor tyrosine kinase-like orphan receptor 1 and antibody-drug conjugates, as well as IM-3050, a fibroblast activation protein targeted radioligand therapy; and IM-4320, an anti-IL-38 immunotherapy candidate. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.", "fullTimeEmployees": 62, "companyOfficers": [{"maxAge": 1, "name": "Dr. Clay B. Siegall Ph.D.", "age": 62, "title": "President, CEO & Chairman", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 1433088, "exercisedValue": 0, "unexercisedValue": 12996163}, {"maxAge": 1, "name": "Dr. Jack  Higgins Ph.D.", "age": 43, "title": "Chief Scientific Officer", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 956342, "exercisedValue": 0, "unexercisedValue": 734891}, {"maxAge": 1, "name": "Dr. Robert J. Lechleider M.D.", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 512488, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Max  Rosett", "age": 33, "title": "Executive VP of Operations, Principal Accounting & Financial Officer and CFO", "yearBorn": 1990, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sandra G. Stoneman Esq., J.D.", "age": 49, "title": "Chief Legal Officer, General Counsel & Corporate Secretary", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 443432, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bruce  Turner M.D., Ph.D.", "age": 59, "title": "Chief Strategy Officer", "yearBorn": 1964, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kinney  Horn", "age": 48, "title": "Chief Business Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 10, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 10, "governanceEpochDate": 1716940800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 14.62, "open": 14.63, "dayLow": 14.46, "dayHigh": 15.4295, "regularMarketPreviousClose": 14.62, "regularMarketOpen": 14.63, "regularMarketDayLow": 14.46, "regularMarketDayHigh": 15.4295, "beta": 1.879, "forwardPE": -5.349091, "volume": 761695, "regularMarketVolume": 761695, "averageVolume": 745577, "averageVolume10days": 860680, "averageDailyVolume10Day": 860680, "bid": 14.71, "ask": 14.75, "bidSize": 100, "askSize": 100, "marketCap": 882142528, "fiftyTwoWeekLow": 4.5, "fiftyTwoWeekHigh": 30.958, "priceToSalesTrailing12Months": 69.55315, "fiftyDayAverage": 17.5666, "twoHundredDayAverage": 13.5102, "currency": "USD", "enterpriseValue": 574061056, "floatShares": 42884337, "sharesOutstanding": 59968900, "sharesShort": 6123723, "sharesShortPriorMonth": 3747870, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.1021, "heldPercentInsiders": 0.17083, "heldPercentInstitutions": 0.61521, "shortRatio": 6.94, "shortPercentOfFloat": 0.108, "impliedSharesOutstanding": 59968900, "bookValue": 4.784, "priceToBook": 3.074833, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -232028000, "trailingEps": -17.58, "forwardEps": -2.75, "enterpriseToRevenue": 45.262, "enterpriseToEbitda": -13.023, "52WeekChange": 1.7859848, "SandP52WeekChange": 0.22256601, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "IMNM", "underlyingSymbol": "IMNM", "shortName": "Immunome, Inc.", "longName": "Immunome, Inc.", "firstTradeDateEpochUtc": 1601645400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "c2147e86-3bc9-3a00-bf6a-53fc4499717d", "messageBoardId": "finmb_108518404", "gmtOffSetMilliseconds": -14400000, "currentPrice": 14.71, "targetHighPrice": 38.0, "targetLowPrice": 33.0, "targetMeanPrice": 35.33, "targetMedianPrice": 35.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 309705984, "totalCashPerShare": 5.164, "ebitda": -44082000, "totalDebt": 1625000, "quickRatio": 10.066, "currentRatio": 10.184, "totalRevenue": 12683000, "debtToEquity": 0.569, "revenuePerShare": 0.427, "returnOnAssets": -0.15156001, "returnOnEquity": -1.54978, "freeCashflow": -18518250, "operatingCashflow": -42911000, "revenueGrowth": -0.565, "grossMargins": -1.7107899, "operatingMargins": -19.77162, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-31"}]